ResMed Inc. logo

RMD

ResMed Inc.

$229.92

Earnings Summary

Revenue
$651.1Mn
Net Profits
$124.64Mn
Net Profit Margins
19.14%

Highlights

Revenue:

ResMed Inc.’s revenue jumped 8.29% since last year same period to $651.1Mn in the Q4 2018. On a quarterly growth basis, ResMed Inc. has generated 10.68% jump in its revenue since last 3-months.

Net Profits:

ResMed Inc.’s net profit jumped 1208.27% since last year same period to $124.64Mn in the Q4 2018. On a quarterly growth basis, ResMed Inc. has generated 17.88% jump in its net profits since last 3-months.

Net Profit Margins:

ResMed Inc.’s net profit margin jumped 1108.15% since last year same period to 19.14% in the Q4 2018. On a quarterly growth basis, ResMed Inc. has generated 6.5% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the ResMed Inc. post its latest quarter earnings

EPS Estimate Current Quarter
1.59
EPS Estimate Current Year
1.59

Highlights

EPS Estimate Current Quarter:

ResMed Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.59 - a 5.3% jump from last quarter’s estimates.

EPS Estimate Current Year:

ResMed Inc.’s earning per share (EPS) estimates for the current year stand at 1.59.

Key Ratios

Key ratios of the ResMed Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
1.49
Return on Assets (ROA)
0.13
Return on Equity (ROE)
0.24
Dividend Per Share (DPS)
0.42

Highlights

Earning Per Share (EPS):

ResMed Inc.’s earning per share (EPS) jumped 10.37% since last year same period to 1.49 in the Q2 2022. This indicates that the ResMed Inc. has generated 10.37% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. ResMed Inc.’s return on assets (ROA) stands at 0.13.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. ResMed Inc.’s return on equity (ROE) stands at 0.24.

Dividend Per Share (DPS):

ResMed Inc. declared 0.42 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-04-29
1.46
1.32
-9.59%
2022-08-12
1.44
1.49
3.47%

Company Information

ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.

Organisation
ResMed Inc.
Headquarters
9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123
Employees
8160
Industry
Health Technology
CEO
Michael Farrell

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*